EP Plenary session - Joint debate on Patents

Patenty a práva šľachtiteľov rastlín (rozprava)

Patents and plant breeders rights (debate)

Vytvorenie jednotnej ochrany patentov - Jednotná ochrana patentov - Jurisdikčný systém pre patentové spory (rozprava)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Patentovanie v podstate biologických procesov (rozprava)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Posilnená spolupráca v oblasti vytvárania jednotnej ochrany patentov (rozprava)

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

MEPs wear t-shirts with a slogan that reads 'Protect innovation against software patents'

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

Parlament rokoval o tom, či by sa malo upustiť od patentov na vakcíny proti ochoreniu COVID-19 a prijal inkluzívnejší program Erasmus+. Na programe bola aj klíma: Poslanci schválili Fond pre spravodlivú transformáciu na pomoc regiónom pri adaptácii na ekologickú transformáciu a vyzvali EÚ, aby urobila viac na ochranu environmentálnych aktivistov. Poslanci rokovali aj o eskalácii izraelsko-palestínskeho konfliktu.

Zásadné body plenárneho zasadnutia: Patenty na vakcíny proti ochoreniu COVID-19, Erasmus+ a životné prostredie

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Parlament opätovne zdôraznil význam bezbariérového prístupu k materiálu na šľachtenie rastlín. Poslanci EP chcú zaručiť, aby mohli európski poľnohospodári inovovať svoje postupy i plodiny, a takto hľadať riešenia klimatickej krízy aj nových ochorení rastlín. Bohaté nadnárodné spoločnosti nesmú mať možnosť patentovať život, získavať monopol, a tak navyšovať ceny potravín.

Ostanú rastliny a semená získané prirodzeným spôsobom bez patentov?

Posledný úsek cesty k jednotnému patentu je poriadne strmý, nový systém však sľubuje racionalizáciu nákladov, ktoré dnes môžu predstavovať aj 32 000 € za patent.

Znižovanie nákladov na patentovanie objavov

Raffaele Baldassarre je presvedčený, že jednotný patent prinesie európskym podnikom veľké výhody. Sophia in 't Veld ukazuje prstom na krajiny Únie porušujúce základné práva.

Sedem dní v Európe: Boj za lepšiu ochranu práv a jednotný patent EÚ

Po 30 rokoch rokovaní sa jednotný európsky patent dostáva do posledného dejstva. Diskutujú Bernhard Rapkay (S&D, Nemecko) a Antonio Masip Hidalgo (S&D, Španielsko).

Dva názory na jednotný európsky patent

Poslanci EP rokujú o jednotnom patente, spochybňujú čestnosť členských štátov a komentujú záchranu španielskych bánk. Reagujú na žiadosť farmárov o zvýšenie cien mlieka.

Európsky patent / prelety lietadiel CIA / Španielsko / mlieko

Poslanci EP opätovne preskúmajú budúcnosť jednotného európskeho patentu. Nedávne rozhodnutie Rady, že jednostranne zmení dohodnutý text, vyvolalo vlnu kritiky.

Problematické patenty

V USA na patentovanie vynálezu potrebujete 2 000 eur, v celej EÚ až 40 000. Všetko by mal zjednodušiť jednotný európsky patent, no jeho zavádzanie sa komplikuje.

Reportér: Patentovanie vynálezu v rámci EÚ

Čochvíľa bude možné chrániť vynález v rámci celej Európy a dokonca s nižším rozpočtom, no treba dotiahnuť detaily. Nechýbajú ani ďalšie správy.

Aktuality: Čakanie na spoločný európsky patent

Čochvíľa bude možné chrániť vynález v rámci celej Európy a dokonca s nižším rozpočtom, no treba dotiahnuť detaily.

Efektívnejšie využívanie zdrojov, patent Spoločenstva a vypočúvanie Komisárov - ukážka toho, čo čaká europoslancov budúci týždeň v Bruseli.

Zobrazujú 21 sa výsledky videí pre ""

EPRS - Key challenges for European patents

Zásadné body plenárneho zasadnutia: Patenty na vakcíny proti ochoreniu COVID-19, Erasmus+ a životné prostredie

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Ostanú rastliny a semená získané prirodzeným spôsobom bez patentov?

Znižovanie nákladov na patentovanie objavov

Sedem dní v Európe: Boj za lepšiu ochranu práv a jednotný patent EÚ

Dva názory na jednotný európsky patent

Európsky patent / prelety lietadiel CIA / Španielsko / mlieko

Problematické patenty

Reportér: Patentovanie vynálezu v rámci EÚ

Aktuality: Čakanie na spoločný európsky patent

Aktuality: Čakanie na spoločný európsky patent

Program EP: Záchrana planéty